相关实验视频
Updated: Jul 2, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
建立和验证免疫治疗后对非小细胞肺癌的生存益处预测模型
Alternative therapies in health and medicine
|February 24, 2024
概括
这项研究开发了一种预测模型,以评估免疫治疗后非小细胞肺癌 (NSCLC) 患者的存活率. 该模型确定了关键的风险因素,帮助临床医生进行个性化治疗并改善结果.
科学领域:
- 在瘤学瘤学.
- 免疫疗法研究 免疫疗法研究
- 生物统计学 生物统计学
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- 免疫疗法已经成为NSCLC的重要治疗方式.
- 在免疫治疗后预测患者的预后仍然是一个临床挑战.
研究的目的:
- 分析接受免疫治疗的非小细胞肺癌 (NSCLC) 患者的预后.
- 构建一个预测模型来评估这些患者的整体生存率.
- 确定影响生存和疾病进展的重大风险因素.
主要方法:
- 对493名接受首次免疫治疗的NSCLC患者的回顾性分析.
- 使用考克斯回归和卡普兰-梅尔方法分析的生存数据.
- 使用C指数和AUC指标开发和验证一个预测模型.
主要成果:
- 多变量分析确定吸烟史,年龄,T阶段和M阶段是显著的风险因素.
- 预测模型表现出很好的准确性,三年AUC为0.761 (培训) 和0.739 (验证).
- 5年AUC为0.763 (培训) 和0.761 (验证),证实了预测能力.
结论:
- 已经开发了一个强大的预测模型,用于NSCLC患者在免疫治疗后的生存率.
- 该模型整合了多种影响因素,以进行全面的风险评估.
- 这种工具可以帮助临床医生量身定制治疗和后续策略,以改善患者的治疗结果.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
267
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
相关概念视频
01:21Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524